Watsons正在泰国和马来西亚启动JCprogram皮肤护理线, Watsons is launching its JCprogram skincare line in Thailand and Malaysia, expanding from Asia's successful markets.

Watsons正在将其日本临床皮肤护理线JCProgram扩大至泰国和马来西亚, Watsons is expanding its Japanese clinical skincare line JCprogram to Thailand and Malaysia, building on its success in China, Taiwan, and Hong Kong. 该品牌由创始人Nobutaka Furuyama博士支持,提供有科学支持的非侵入性治疗,并有临床证明的结果。 The brand, backed by founder Dr. Nobutaka Furuyama, offers science-backed, non-invasive treatments with clinically proven results. 它的“1:1无缝美学复制”技术使三个产品系列具有力量,目标是减少皱纹、水合和皮肤修补。 Its “1:1 Seamless Aesthetic Replication” technology powers three product series targeting wrinkle reduction, hydration, and skin repair. 这一举动与亚洲消费者对有效、负担得起的审美解决方案的日益增长的需求相一致。 The move aligns with rising Asian consumer demand for effective, affordable aesthetic solutions. 随着全球市场的增长预计到2033年将达到350亿美元,华生公司正在利用其8 000多家亚洲商店加强其在临床皮肤护理方面的领导地位。 With a growing global market projected to reach $35 billion by 2033, Watsons is using its 8,000+ Asian stores to strengthen its leadership in clinical skincare.